You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 1, January 1951 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CLINICAL TRIAL WITH CHLORAMPHENICOL IN OCULAR INFECTIONS

IRVING H. LEOPOLD, M.D.

AMA Arch Ophthalmol. 1951;45(1):44-52.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IT IS well known that four criteria are of major importance in evaluating antibiotics in ophthalmology; namely, (1) ease of penetration into ocular tissues when the drug is locally or systemically administered; (2) toxicity for ocular tissues; (3) effectiveness against standard experimental ocular infections; (4) effectiveness against clinical ocular infections.

The ease of administration, cost, availability, general tissue toxicity and range of antibiotic activity are also of importance, but these are not solely ophthalmologic problems. Data concerning the four main criteria have been reported for penicillin,1 streptomycin,2 bacitracin3 and aureomycin.4 Recently, an evaluation of the ocular penetration and toxicity of chloramphenicol has been reported.1b It was found that chloramphenicol is stable in solution and penetrates readily into the ocular tissues and fluids after systemic (oral and intravenous) and local administration. These studies with chloramphenicol have been continued with the intent of evaluating its clinical effectiveness.5 . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA

From the Research and Clinical Department of Wills Hospital.


Footnotes

Presented before the Section of Ophthalmology of the Clinical Congress of the American College of Surgeons, Boston, Oct. 25, 1950.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1951 American Medical Association. All Rights Reserved.